Aceto traded at $14.26 this Thursday March 10th, increasing $1.69 or 13.40 percent since the previous trading session. Looking back, over the last four weeks, Aceto gained 8.77 percent. Over the last 12 months, its price rose by 0.92 percent. Looking ahead, we forecast Aceto to be priced at 13.88 by the end of this quarter and at 12.79 in one year, according to Trading Economics global macro models projections and analysts expectations.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Aceto Corporation (Aceto) is a pharmaceutical and specialty chemicals company. The Company markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The Company distributes more than 1,100 chemical compounds, which are used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Company operates in three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment makes nutritional products and drugs for human consumption. The Pharmaceutical Ingredients segment is engaged in generic drugs manufacturing for pharmaceutical companies. The Performance Chemicals segment makes a range of chemical products for multiple uses in a variety of industries.